PREPARATION & COMPILATION OF ACTD DOSSIER (PART II QUALITY)
ACTD is a critical document for drug substance and produces registration in ASEAN region. The document is essentially divided into 4 parts. Each part provides information under specific head. Out of all the parts, the part II is most important. This part not only evaluates technical suitability of the product but also determines the suitability of active drug and Excipients.
The major stress in this part is on formulation, manufacturing, stability and process validation. The information required under this part is suitably detailed in this article.
2. Food and Administration, Philippines [Internet]. ACTD/ATR Drug Registration Requirements; 2005
[cited 2015 March 30]. Available from: http://www.fda.gov.ph/industry-corner/downloadables/217-requirements-for-drug-registration/95567-actd-atr-requirements
3. Javroongrit Y. The ICH-Global Cooperation Group Meeting, Regional Update – ASEAN PPWG [Internet]. [Japan] 2012 June [cited 2015 March 15]. Available from:
4. National Pharmaceutical Control Bureau Ministry of Health Malaysia [Internet]. Malaysia: Drug Registration Guidance document; 2011 April [cited 2015 March 29]. Available from:
5. Health Sciences Authority [Internet]. Singapore: ACTD - Guidelines on Drug Registration; 2011 [cited 2015 March 27]. Available from:
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM